人Tnfrsfl 1b-N端多狀的原核表达、纯化及其初步分析

目的 对原核表达和可溶性纯化后的Tnfrsf11b蛋白氨基端的24～106位肽段进行二级结构分析.方法 根据已经发表的人Tnfrsf11b氨基酸序列,利用BLAST程序进行同源性分析,确定所要构建的Tnfrsf11b N 端CRD功能结构域;将目的 基因片段克隆入表达载体 pGEX-6P-1并转化大肠杆菌BL21(DE3),于16.C、0.1 mmol/L IPTG 诱导25～30 h可获得可溶性融合蛋白,经过Glutathione SepharoseTM4 B 亲和层析纯化和 PreScission Protease 酶切,洗脱的蛋白样品经过Superdex75凝胶预装柱进一步纯化,最终获得可溶性、高纯度的蛋白;对目标蛋白进行圆二色谱分析.结果 获得重组质粒pCEX-6P-1-tnfrsf11b并在大肠杆菌中可溶性表达,经亲和层析、酶切、分子筛层析后获得了可溶的、高纯度的Tnfrsf11bN 端功能结构域蛋白并对其进行了圆二色谱分析,发现目标蛋白富含β-sheet.结论 高含量的β-sheet 更有利于蛋白质参与与相互作用,这对其功能的发挥有着重要意义;对此进行研究可以更好的理解这种相互作用,并为进一步研究Tnfrsf11bN端的结构和功能奠定了基础.     

失血性大鼠休克后肠、肝、肺组织中细胞因子表达、释放时相及其伴随的病理变化

目的：探讨休克后促炎细胞因子的表达、释放时相及伴随的肠、肝、肺组织病理变化。方法：80只SD大鼠随机均分为失血性休克组和对照组。采用RT-PCR、ELISA方法检测失血性休克后30、60、90min及复苏后30、90min肠、肝、肺组织内TNF-α、IL-6 mRNA表达及血清中TNF-α、IL-6含量；HE和IHC染色检测伴随的组织病理变化。结果：①休克30min时，肠、肝、肺内的促炎细胞因子表达未见升高；60min时肠道先出现TNF-αmRNA表达升高（P〈0．05）：而肝脏在90min开始表达升高（P〈0．05），肺脏则在复苏后30min开始表达升高（P〈0．05）。复苏后90min肠、肝、肺的细胞因子表达都继续显著升高（P〈0．01）。②TNF-α 在肠、肝、肺的表达升高最早，其后为IL-6 mRNA。③30min时门静脉和外周血中TNF-α、IM的含量与对照组相比无显著差异，而60min时门静脉血中含量显著升高（P〈0．01）。④休克后肠黏膜坏死脱落；肝组织结构紊乱、肝窦增宽、肝细胞变性坏死；肺脏间质水肿、炎症细胞浸润。结论：失血性休克时细胞因子的释放顺序是肠道、肝脏和肺脏，推测存在“肠-肝-肺”细胞因子释放轴的可能，有待进一步确定。     

化疗药物性静脉炎及渗漏损伤的动物实验模型研究概况

化疗药物性静脉炎及渗漏损伤的动物实验模型是研究体内化疗药物性静脉炎及渗漏损伤的发病机制和评价各种治疗方法的重要条件。化疗药物性静脉炎及渗漏损伤的实验研究进展缓慢,其主要原因是缺乏理想的动物模型。依文献报道,化疗药物性静脉炎模型主要以大白兔耳缘静脉注射长春瑞滨等化疗药物为多见,化疗药物渗漏损伤模型主要以大鼠及大白兔背部皮下注射盐酸阿霉素等化疗药物为多见。文章就近年来常用的一些化疗药物性静脉炎及渗漏损伤的动物模型综述如下。     

成人先天性肺内支气管囊肿的影像学诊断

目的:探讨成人先天性肺内支气管囊肿在CT、MRI表现上的特征。方法:37例经手术及病理证实的肺内支气管囊肿;男25例,女12例,年龄18～63岁,平均35岁。均行X胸片,24例行CT平扫及增强扫描,13例行MRI检查。结果:分布在右肺16例,左肺21例。形态以圆形为主,可以呈葫芦状、长条状或不规则形。22例囊肿含有液体,8例含气体,6例含有气液面,4例含有曲菌球,囊壁钙化7例,呈点状和弧线状。囊壁见有轻-中度强化,其中以含液囊肿较明显,囊肿周围气肿15例。结论:大部分成人先天性肺内支气管囊肿的CT、MRI表现有一定的特征,有助于术前诊断。     

Early changes in hemoglobin and hematocrit levels after packed red cell transfusion in patients with acute anemia

BACKGROUND: Equilibration of hemoglobin concentration after transfusion has been estimated to take about 24 hours, but some studies have shown that earlier measurements reflect steady-state values in persons who have not bled recently. This study was aimed at assessing the changes over time in hemoglobin concentration after transfusion in acutely anemic patients because of recent bleeding. STUDY DESIGN AND METHODS: Thirty-two normovolemic patients recovering from an acute bleeding episode who were no longer thought to be bleeding and who received a 2- unit red cell transfusion were studied. At baseline and 15, 30, 60, and 120 minutes and 24 hours after transfusion, hemoglobin concentration and hematocrit values were measured. RESULTS: The administration of 2 units of packed red cells elicited a 24-hour increase of 22.4 +/− 6.8 g per L in hemoglobin concentration. Hemoglobin values were not different at any of the defined posttransfusion times. Hematocrit levels experienced similar changes over time. Agreement between 15-minute and 24-hour values was excellent, as only 6 percent of patients exhibited a clinically significant difference (> 6 g/L) between the hemoglobin measurements. CONCLUSION: Hemoglobin and hematocrit values rapidly equilibrate after transfusion in normovolemic patients who are recovering from an acute bleeding episode. This fact would allow a rapid assessment of the effects of transfusion and of the recurrence of bleeding in patients remaining at risk.     

去痛片中四组分的HPLC测定

以十八烷基硅烷键合硅胶为固定相，采用ＨＰＬＣ法测定去痛片中氨基比林、非那西丁、咖啡因、苯巴比妥的含量。各组分的回收率分别为９９．８±０．５０％、９９．７±０．７６％、９９．３±０．５４％、９９．６±０．５８％。     

青山抗癌注射液抑制小鼠肿瘤生长的实验研究

目的：研究青山抗癌注射液对动物移植性肿瘤生长的影响．方法：以小鼠移植性肉瘤S180和肝癌H22为模型，以顺铂(DDP)为阳性对照，生理盐水(阳)为阴性对照，观察青山抗癌注射液对肿瘤生长的影响。结果：青山抗癌注射液不同剂量组对小鼠移植性肉瘤S180和肝癌H22的生长均显示了明显的抑制作用，与NS对照组相比，P＜0.01，且呈现出量效关系．结论：青山抗癌注射液具有抑制肿瘤生长的作用.     

诺氟沙星合成工艺概述

对诺氟沙星的生产工艺作了简要述评,着重对生产上存在的技术问题及可能解决的途径提出了看法。     

In vitro and in vivo effects of clindamycin on polymorphonuclear leukocyte function.

The effects of clindamycin on polymorphonuclear leukocytes (PMNLs) were evaluated in vitro and in vivo in an experimental model and in immunocompromised patients with and without infection. Chemotaxis, chemiluminescence, and bactericidal capacity were evaluated using PMNLs preincubated with clindamycin in different concentrations. In the three phases of the study, clindamycin at a concentration of 2 mg/L significantly increased PMNL function. In contrast, when higher concentrations were used, PMNL function was not modified and in some cases it was decreased. Our findings suggest that clindamycin, in concentrations of 2 mg/L, positively modifies PMNL function.